Analysts' Actions: HPQ NTAP GILD LSI AMGN
NEW YORK (TheStreet) -- CHANGE IN RATINGS
Arch Coal (ACI) upgraded at Argus from Hold to Buy, Argus Research said. Valuation call, based on a $10 price target. Natural gas now also appears less attractive, relative to coal.
Alexion (ALXN) rated new Neutral at Lazard. Stock is already pricing in solid growth for Soliris.
Amgen (AMGN) upgraded at Lazard from Sell to Buy, Lazard said. New analyst has a $101 price target. Company has strong growth prospects and an attractive pipeline.
American Tower (AMT) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. Valuation call, based on a $75 price target.
AES (AES) downgraded to hold at TheStreet Ratings.
Alliance One International (AOI) downgraded to sell at TheStreet Ratings.
Atmel (ATML) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Company lacks near-term visibility. $6.50 price target.
Coach (COH) upgraded at Canaccord from Hold to Buy, Canaccord Genuity said. $71 price target. Investors have overreacted and China can drive growth in the coming years.
Dell (DELL) rated new Neutral at UBS. $12.50 price target. Troubling near term, but more positive long term.
Gilead (GILD) downgraded at Lazard to Neutral, Lazard said. New analyst sees increased competition for the company's HCV franchise.
Health Net (HNT) downgraded at BMO to Underperform, BMO Capital said. $14 price target. Company will likely continue to struggle for several quarters.
Hewlett-Packard (HPQ) rated new Sell at UBS. $16 price target. CEO turnover, lack of focus, and poor financial results.
LSI Logic (LSI) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $9 price target. Solid-state and networking businesses should drive margin expansion.
NetApp (NTAP) rated new Buy at UBS. $45 price target. Forecast above consensus growth and attractive valuation.
Oil States (OIS) rated new Buy at Dahlman. $99 price target. Accommodations and Offshore segments should drive growth.
Children's Place (PLCE) downgraded at BMO from Outperform to Market Perform, BMO Capital said. $55 price target. Company lacks near-term catalysts. Market Perform rating.